phrykt

AtriCure, Inc. (ATRC): who owns it and who trades it

As of Nov 16, 2026, ATRC insiders reported 19 open-market sales worth $5.1M and no purchases in the last 12 months, with 28% of the sale value made under pre-set 10b5-1 plans. The largest seller was Salvatore Privitera (Chief Technical Officer), with $1.4M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling AtriCure

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Funds mostly bought. Famous investors and Congress were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns ATRC

253 funds and institutions reported ATRC shares worth $1.6B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 8.8%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.8.8%
Wellington Management Group LLP6.9%
Vanguard Portfolio Management LLC6.2%
Hood River Capital Management LLC5.7%
Alliancebernstein L.P.5.5%
Vanguard Capital Management LLC4.3%
Nomura Asset Management International Inc.3.4%
California State Teachers Retirement System3.2%
Goldman Sachs Group Inc3.2%
State Street Corp2.7%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.4.47M8.84%$125M+11%
Wellington Management Group LLP3.50M6.90%$97.8M+3%
Vanguard Portfolio Management LLC3.13M6.18%$87.5M+16%
Hood River Capital Management LLC2.91M5.74%$81.3M-7%
Alliancebernstein L.P.2.77M5.47%$79M-15%
Vanguard Capital Management LLC2.19M4.33%$61.3M+2%
Nomura Asset Management International Inc.1.73M3.42%$48.5M-4%
California State Teachers Retirement System1.63M3.23%$58.4M+2627%
Goldman Sachs Group Inc1.60M3.16%$44.7M-4%
State Street Corp1.39M2.74%$38.9M+7%
Marshall Wace, LLP1.33M2.63%$37.3M-9%
Geode Capital Management, LLC1.32M2.61%$36.9M+8%
Arrowstreet Capital, Limited Partnership1.30M2.56%$36.3M+367%
Dimensional Fund Advisors LP1.04M2.06%$29.2M+5%
GW&K Investment Management, LLC949,5161.87%$26.6M-1%
Neuberger Berman Group LLC947,9821.87%$26.6M-10%
Champlain Investment Partners, LLC938,5671.85%$26.3M-3%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.897,4191.77%$25.1M-15%
Bank of America Corp874,3701.73%$24.5M+14%
Kennedy Capital Management LLC857,7871.69%$24M+3%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, ATRC insiders reported $0 of open-market purchases and $5.1M of sales. 28% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$5.1M
19 trades, 9 people
Sales under a 10b5-1 plan
28%
Share of sale value
Latest trade
Nov 6, 2026
Filed Nov 10, 2026

Purchases and sales by month

$1.4M$1.4MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 6, 2026B Kristine JohnsonDirectorSale2,452$58.48$143KForm 4
Nov 4, 2026Salvatore PriviteraChief Technical OfficerSale plan8,404$65.00$546KForm 4
Sep 23, 2026Salvatore PriviteraChief Technical OfficerSale plan4,519$60.00$271KForm 4
Sep 11, 2026Regina E GrovesDirectorSale5,313$54.22$288KForm 4
Sep 8, 2026Salvatore PriviteraChief Technical OfficerSale plan3,657$55.00$201KForm 4
Sep 2, 2026Salvatore PriviteraChief Technical OfficerSale plan7,763$52.50$408KForm 4
Aug 24, 2026Karl S. DahlquistChief Legal OfficerSale9,370$48.89$458KForm 4
Aug 5, 2026Karen PrangeDirectorSale3,564$38.80$138KForm 4
Aug 5, 2026Maggie YuenDirectorSale3,500$38.42$134KForm 4
Jul 29, 2026Justin J NozneskyChief Mktg & Strategy OfSale6,182$38.80$240KForm 4
Jul 28, 2026Vinayak DoraiswamyChief Scientific OfficerSale6,000$38.88$233KForm 4
Jul 28, 2026Sven WehrweinDirectorSale25,000$37.84$946KForm 4
May 20, 2026Karen PrangeDirectorSale3,000$28.65$86KForm 4
May 15, 2026Vinayak DoraiswamyChief Scientific OfficerSale5,000$28.13$141KForm 4
Mar 12, 2026Vinayak DoraiswamyChief Scientific OfficerSale5,000$29.83$149KForm 4
Nov 26, 2025Justin J NozneskyChief Mktg & Strategy OfSale5,166$37.29$193KForm 4
Nov 25, 2025Sven WehrweinDirectorSale4,967$38.00$189KForm 4
Nov 24, 2025Sven WehrweinDirectorSale5,033$37.32$188KForm 4
Nov 21, 2025Maggie YuenDirectorSale3,000$35.72$107KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Salvatore PriviteraChief Technical Officer–$1.4MNov 4, 2026
Sven WehrweinDirector–$1.3MJul 28, 2026
Vinayak DoraiswamyChief Scientific Officer–$523KJul 28, 2026
Karl S. DahlquistChief Legal Officer–$458KAug 24, 2026
Justin J NozneskyChief Mktg & Strategy Officer–$433KJul 29, 2026
Regina E GrovesDirector–$288KSep 11, 2026
Maggie YuenDirector–$242KAug 5, 2026
Karen PrangeDirector–$224KAug 5, 2026
B Kristine JohnsonDirector–$143KNov 6, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ATRC short interest

Moderate short interest. 9.6% of ATRC shares are sold short: about 1 share in 10. Over the last 12 reports the number of shares short went up 10%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 4.89M ATRC shares were sold short, 9.6% of the shares outstanding, up 0.1% from the report before. At the average daily volume of 643,486 shares, buying them all back would take about 7.6 trading days (days to cover).

Shares short, % of all shares

9.61%May 15Oct 3010.0%

Days to cover

7.6May 15Oct 308.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20264.89M9.61%+0%643,4867.6
Oct 15, 20264.89M9.61%+1%937,5005.2
Sep 30, 20264.82M9.47%+13%1.85M2.6
Sep 15, 20264.28M8.41%+3%1.18M3.6
Aug 31, 20264.14M8.14%+6%718,4835.8
Aug 14, 20263.92M7.71%+2%642,5386.1
Jul 31, 20263.86M7.60%-21%1.04M3.7
Jul 15, 20264.86M9.61%+9%856,7055.7
Jun 30, 20264.45M8.79%+29%1.25M3.6
Jun 15, 20263.44M6.80%+1%706,6584.9
May 29, 20263.40M6.72%-23%844,2684.0
May 15, 20264.43M8.75%+15%979,6334.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded ATRC

Since Nov 17, 2024, 1 member of Congress reported 3 purchases and 1 sale of ATRC. The latest was a sale by Gilbert Ray Cisneros, Jr. on Sep 29, 2026, reported Oct 12, 2026.

Purchases 3Sales 1

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Sep 29, 2026Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfOct 12, 2026Report
Aug 20, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfSep 10, 2026Report
Mar 3, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfApr 7, 2026Report
May 6, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfJun 6, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

AtriCure company events

AtriCure filed 7 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 3, 2026.

  1. Nov 3, 2026ResultsReleased financial results. Filing
  2. Jul 23, 2026ResultsReleased financial results. Filing
  3. May 19, 2026LeadershipAt the AtriCure, Inc. 2026 Annual Meeting of Stockholders held on May 18, 2026, the stockholders of the Company approved an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan. Filing
  4. May 6, 2026ResultsAmended an earlier report. Released financial results. Filing
  5. May 5, 2026ResultsReleased financial results. Filing
  6. Feb 17, 2026ResultsReleased financial results. Filing
  7. Jan 12, 2026AgreementAtriCure, Inc. and its wholly owned subsidiary, AtriCure, LLC (together with the Company, the “ Borrowers ”), entered into a First Amendment to Credit Agreement (as amended, the “ Credit Agreement ”) among the Borrowers, JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

AtriCure financials

Famous investors that hold ATRC

4 of the 50 well-known investors we track reported holding ATRC in their latest 13F filing. The largest position is Ken Griffin's, worth $31.9M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026567,483$31.9M0.0%+220%
Jim Simons · Renaissance TechnologiesQ3 2026321,000$18M0.0%+37%
Steve Cohen · Point72 Asset ManagementQ3 2026117,900$6.6M0.0%-80%
Ray Dalio · Bridgewater AssociatesQ3 202642,194$2.4M0.0%-45%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named ATRC in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Wellington Management Group LLP13G/A8.1%
Nov 16, 2026Wellington Management Group LLP13G/A8.1%
Oct 30, 2026Vanguard Portfolio Management13G/A7.2%
Oct 30, 2026Vanguard Portfolio Management13G/A7.2%
Oct 5, 2026BlackRock, Inc.13G/A15.4%
Oct 5, 2026BlackRock, Inc.13G/A15.4%

Questions about AtriCure, Inc. (ATRC) stock

Who owns the most ATRC stock?

The largest reported owner of AtriCure, Inc. (ATRC) is BlackRock, Inc., with 8.8% of the company. In total, 253 funds and institutions reported holding ATRC at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are ATRC insiders buying or selling?

In the last 12 months, ATRC insiders reported no open-market purchases and 19 sales worth $5.1M. The latest trade was on Nov 6, 2026. See every trade.

What is the short interest in ATRC?

As of Oct 30, 2026, 4.89M ATRC shares were sold short, 9.6% of the shares outstanding, up 0.1% from the report before. At the average daily volume of 643,486 shares, buying them all back would take about 7.6 trading days (days to cover). See the history.

Have members of Congress traded ATRC?

Yes. 1 member of Congress reported 3 purchases and 1 sale of ATRC since Nov 17, 2024. The latest was reported on Oct 12, 2026. See the trades.

Which famous investors hold ATRC?

4 of the 50 well-known investors we track reported ATRC in their latest 13F filing, including Ken Griffin, Jim Simons, Steve Cohen. The largest position is worth $31.9M. See all holders.

Executive pay

AtriCure's chief executive was paid a total of $9.2M for the year ended Dec 31, 2025, down 17% from $11.1M the year before. In the last 12 months, AtriCure's executives and directors bought no stock on the open market and sold $5.1M.

Chief executive, total pay$9.2MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$14.9MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$3.2MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.